Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

HIV is currently the only disease carrying a felony charge if someone knowingly transmits it to another person. The Senate ...

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

Ten suspects were arrested on Saturday (March 15) in a sweeping operation conducted by the National Drug Authority (NDA) in Kampala, during which government drugs and tampered-with diagnostic kits ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...

A patient told MassLive she was horrified to receive a phone call from her surgeon post-operation saying she should be tested for bloodborne pathogens.

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...